1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

22 Oct 2024
Admin
News Article

Akums Inks Pact with Triple Hair Group, Canada for Treating Alopecia

Akums inks licensing pact with Triple Hair Group, Canada for patented topical solution targeting alopecia

Overview

Akums Drugs & Pharmaceuticals a CDMO (contract development and manufacturing organisation) has inked a strategic partnership with Triple Hair Group, a Canadian company specializing in the development of innovative treatments for androgenic alopecia. This is for the exclusive licensing of their patented topical formulation for the Indian market which combines three medicaments to combat alopecia, a common condition affecting millions in India and worldwide.

About Topical Solution & Its Working

The newly licensed topical solution is designed to provide a comprehensive approach to hair care.
It works to prevent hair fall, stimulate new hair growth, and enhance hair thickness and density, offering a one-stop solution for those battling hair thinning and baldness.
This cutting-edge formula promises a convenient and effective option for users who prefer topical treatments, with the potential to improve compliance and outcomes for individuals struggling with hair loss.

Words from the MD: Akums

Sanjeev Jain, managing director, Akums said, “The company’s collaboration with Triple Hair marks a significant step towards expanding our dermatology portfolio and providing innovative and effective solutions for hair care in the Indian market.”

Vision Behind Collaboration

This collaboration aligns with our vision of offering cutting-edge solutions that cater to the evolving needs of our customers.
This patented formulation is set to revolutionize the way alopecia is treated in India, and we are confident that this product will help many people regain their confidence and self-esteem, said Sandeep Jain, managing director, Akums.

Words from the CEO: Triple Hair

“One of the great advantages of this partnership is that Akums will be directly involved in the regulatory process, including an upcoming phase III clinical trial in India. We expect to start the process in the coming weeks so that we can commercialize Therapy-07 in India as soon as possible,” stated Jean-Philippe Gravel, CEO, Triple Hair.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!